Clinical Trials Directory

Trials / Completed

CompletedNCT04529551

CSD1601: A Study to Evaluate the Exposure to Tar and Nicotine From Two Cigarette Products That Contain a Menthol Capsule in the Filter

CSD1601: A Crossover Study to Evaluate the Exposure to Tar and Nicotine From Two Cigarette Products That Contain a Menthol Capsule in the Filter

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
55 (actual)
Sponsor
RAI Services Company · Industry
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

This study will evaluate exposure to tar and nicotine from two cigarette products that contain a menthol capsule in the filter, and provide a basis for comparing mouth-level exposure when smokers smoke the two cigarette products.

Detailed description

Subjects will be randomly assigned to the order in which they will smoke two study cigarette products (including one comparator product and one test product). Subjects will smoke each study product exclusively for approximately one week prior to a test visit, with a different product smoked each week over a two-week period. Cigarette butts will be collected the day prior to each test visit for determination of Yield-in-Use (YIU) tar and nicotine levels. Blood samples will be collected at each test visit for determination of blood cotinine levels. Subjects will provide responses to questions during each test visit to assess their cigarette smoking and cigarette butt collection behavior during the preceding day.

Conditions

Interventions

TypeNameDescription
OTHER1601AA filtered, king size cigarette with a menthol capsule in the filter.
OTHER1601BA filtered, king size cigarette with a menthol capsule in the filter.

Timeline

Start date
2016-04-08
Primary completion
2016-05-02
Completion
2016-05-02
First posted
2020-08-27
Last updated
2022-06-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04529551. Inclusion in this directory is not an endorsement.